Kinaxis will help Alvogen effectively manage its product introduction and tender processes to determine project feasibility and impact across the supply chain
Supply chain management software firm, Kinaxis, announced Alvogen has selected it to create a more connected supply chain to manage growth. The companies aim to develop end-to-end visibility across the entire supply chain, with the ability to manage the network via an integrated planning platform.
Alvogen focuses on developing, manufacturing and selling generic, brand, over the counter (OTC) and biosimilar products for patients around the world. When searching for a partner, the company chose Kinaxis’ RapidResponse platform, concurrent planning and a suite of applications to deliver the connected and collaborative supply chain it needs to scale its business.
The platform’s always-on capabilities give Alvogen the confidence in its decision-making, Kinaxis says, while improving the trust and transparency within the supply chain. This is designed to help reduce inefficiencies, costs and the chance of obsolescent products as well as streamline operations across its complex global supply chain. Additionally, Kinaxis will help Alvogen effectively manage its product introduction and tender processes to determine project feasibility and impact across the supply chain.
“Alvogen’s purpose as an organisation is to make people’s lives better by producing high-quality medicines and making them more accessible to those who might otherwise not be able to afford them,” said Stephen Fecho, US VP, Supply Chain & Third Party Operations at Alvogen. “To bring this purpose to life, we need a supply chain that offers complete visibility, and enables us to be more responsive to global change and disruption. We selected Kinaxis RapidResponse because of its ability to deliver a proven integrated planning platform with the ability to quickly realise business benefits.”
“Life sciences and pharmaceutical supply chains have never been so important, yet have also never been faced with such disruption, making transparency and agility vital to success,” said John Sicard, CEO, Kinaxis. “We are thrilled to have been selected by Alvogen to help them take a truly innovative and future-looking approach to their supply chain. By enabling end-to-end visibility and concurrent planning, we help Alvogen get their life-saving medications to customers across the globe in the most streamlined, efficient manner possible – a game-changer for its customers.”